Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) Receivables - Other (2016 - 2025)

Plus Therapeutics has reported Receivables - Other over the past 13 years, most recently at $322000.0 for Q4 2025.

  • Quarterly Receivables - Other fell 43.61% to $322000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $322000.0 through Dec 2025, down 43.61% year-over-year, with the annual reading at $322000.0 for FY2025, 43.61% down from the prior year.
  • Receivables - Other was $322000.0 for Q4 2025 at Plus Therapeutics, down from $1.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $1.0 million in Q2 2025 and troughed at $73000.0 in Q3 2022.
  • The 4-year median for Receivables - Other is $446500.0 (2024), against an average of $466000.0.
  • Year-over-year, Receivables - Other rose 24.66% in 2023 and then plummeted 43.61% in 2025.
  • A 4-year view of Receivables - Other shows it stood at $73000.0 in 2022, then increased by 24.66% to $91000.0 in 2023, then skyrocketed by 527.47% to $571000.0 in 2024, then plummeted by 43.61% to $322000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Receivables - Other are $322000.0 (Q4 2025), $1.0 million (Q2 2025), and $571000.0 (Q4 2024).